Sign in

CIK 0001802768 · Large accelerated filer

Royalty Pharma plc

Sign in to watch
Ticker
RPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
(212) 883-0200
Business address
110 EAST 59TH STREET, NEW YORK, NY, 10022
  1. 4 Planned sale EVP, Research & Investments sold 41,576 shares at an average $39.15 ($1,627,815)
  2. 4 Planned sale EVP, Investments & CLO sold 110,000 shares at $39.77 ($4,375,008)
  3. 4 Planned sale EVP & CFO sold 69,582 shares at $39.87 ($2,773,956)
  4. 4 Planned sale EVP, Research & Investments sold 41,575 shares at an average $39.92 ($1,659,489)
  5. 4 Planned sale EVP & CFO sold 69,582 shares at an average $38.55 ($2,682,505)
  6. 4 Planned sale EVP, Investments & CLO sold 135,426 shares at an average $38.34 ($5,192,656)
  7. 4 Planned sale EVP & CFO sold 69,594 shares at an average $39.30 ($2,735,329)
  8. 4 Grant or award CEO, Chairman of the Board acquired 36,559 shares (grant or award)
  9. 4 Grant or award EVP & CFO acquired 6,168 shares (grant or award)
  10. 4 Grant or award EVP, Investments & CLO acquired 6,168 shares (grant or award)
  11. 4 Grant or award EVP & Vice Chairman acquired 6,168 shares (grant or award)
  12. 4 Grant or award EVP, Research & Investments acquired 4,626 shares (grant or award)
  13. 4 Grant or award Director acquired 1,047 shares (grant or award)
  14. 4 Open-market sale Director sold 33,500 shares at $36.23 ($1,213,749)
  15. 4 Grant or award CEO, Chairman of the Board acquired 21,901 shares (grant or award)
  16. 4 Grant or award EVP & CFO acquired 3,696 shares (grant or award)
  17. 4 Grant or award EVP, Investments & CLO acquired 3,696 shares (grant or award)
  18. 4 Grant or award EVP & Vice Chairman acquired 3,696 shares (grant or award)
  19. 4 Grant or award EVP, Research & Investments acquired 2,772 shares (grant or award)
  20. 4 Grant or award Director acquired 8,558 shares (grant or award)

Page 4 of 18 · 342 filings